SONODA Shunro

J-GLOBAL         Last updated: Jan 18, 2008 at 00:00
 
Avatar
Name
SONODA Shunro
Degree
MD.& Ph.D(Kyushu University)

Research Interests

 
 

Research Areas

 
 

Academic & Professional Experience

 
1971
 - 
1974
Osaka Public Health Institute, Virus Laboratory, Chief
 
1974
 - 
1980
Ehime School of Medicine, Department of Bacteriology, Associate Professor
 
1980
 - 
1984
Ehime Prefectural Institute of Public Health, Dirctor
 
1984
 - 
1989
Kagoshima University, Faculty of Medicine, Department of Virology, Associate Professor
 
1990
   
 
Kagoshima University, Faculty of Medicine, Department of Virology, Professor and Chairman.
 

Education

 
 
 - 
1968
Graduate School, Division of Medicine, Kyushu University
 
 
 - 
1963
Faculty of Medicine, Kyushu University
 

Misc

 
Altered HLA antigens expressed on T and B lymphocytes of adult T-cell leukemia/lymphoma patients and their relatives
International Journal of Cancer   40(5)    1987
HLA haplotype linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy : Comparison with adult T-cell leukemia/lymphoma
Annals of Neurology   23(Supplement)    1988
Retrovirus infection and neurological disorders
Current Opinion Neurology Neurosurgery   4(2)    1991
Immunogenetic factors involved in the pathogenesis of adult T-cell leukemia and HTLV-I-associated myelopathy
Advances in adult T-cell leukemia and HTLV-I Research. Gann Monograph on Cancer Research   39(1)    1992

Books etc

 
Ethnically-defined immunoigenetic factors involved in the pathogenesis of HTLV-I-associated diseases
Biotest Bulletin   1993   
HLA and HTLV : 12th International Histocompatibility Workshop study.
In HLA : genetic Diversity and Medical Implication(ed D. Charron)   1997   

Works

 
Epidemiological study on ATL
1987 - 1998
ATL development of symptoms prevention by green tea
2000 - 2001
IFN-alpha and gamma medical treatment of ATL by combined use
2000

Research Grants & Projects

 
Genetic Epidemology of Human T-cell leukemia
Immunotherapy of ATL
Prevention of Mother-to-child infection
Development of ATL vaccine